tiprankstipranks
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2

Alnylam Pharma (0HD2) Stock Investors

1 Followers
Based on 728,053 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GB:0HD2
On average, investors allocate 3.06% of their portfolios to GB:0HD2
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0HD2

0.4%
Last 7
Days
6.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0HD2, out of 728,053 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0HD2 Investor Activity

No data currently available
Based on the activity of 13,680 investors who made their portfolios public
The table shows changes in 0HD2 in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0HD2 Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
4.11%
-0.37%
-0.37%
319.59B
Healthcare
Trade Desk
4.78%
-0.51%
-2.18%
39.60B
Technology
ServiceNow
4.03%
+0.12%
+0.15%
150.84B
Technology
Block
4.53%
-1.25%
-6.79%
45.25B
Technology
AbbVie
5.62%
+0.01%
-3.23%
286.26B
Healthcare
GE Aerospace
5.46%
+0.70%
+5.35%
168.04B
Industrials
Cisco Systems
4.55%
-1.09%
-5.24%
195.33B
Technology
Mercadolibre
5.30%
-0.47%
-2.35%
71.78B
Consumer Cyclical
Arista Networks
4.23%
-0.34%
-1.45%
82.29B
Technology
DraftKings
7.11%
-1.06%
-3.36%
37.89B
Consumer Cyclical
Based on the activity of 728,053 active portfolios
Open your Smart Portfolio

0HD2 Investor Analysis

GB:0HD2 investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.5%
of GB:0HD2 holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
GB:0HD2 investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
43.8%
of GB:0HD2 holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
GB:0HD2 investors over 55

Over 55

12.4%
Last 30 days
Holdings Change
46.7%
of GB:0HD2 holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of GB:0HD2 stock investors
See who invests in 0HD2 according to age group and performance.

FAQ

How many retail Investors hold GB:0HD2?
<0.1% of TipRanks' retail investors hold GB:0HD2 in their portfolios.
    What is GB:0HD2 Investor Sentiment?
    GB:0HD2’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GB:0HD2 in the last 7 days?
      ▲ 0.4% of TipRanks' retail investors changed their holding of GB:0HD2 in the last 7 days.
        What percentage of retail investors changed their holding of GB:0HD2 in the last 30 days?
        ▼ 6.7% of TipRanks' retail investors changed their holding of GB:0HD2 in the last 30 days.
          What is the average age of retail investors who hold GB:0HD2?
          The average age of GB:0HD2 Holders is over 55.
            What other stocks have GB:0HD2 investors also bought?
            GB:0HD2 Investors also bought MRK, TTD, NOW, SQ, ABBV, GE, CSCO, MELI, ANET, DKNG.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis